Legal Representation
Attorney
GLENN A GUNDERSEN
USPTO Deadlines
Application History
47 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 12, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 12, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 1, 2023 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Aug 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 31, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jul 31, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jul 31, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 10, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 10, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jul 10, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 7, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Jan 13, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 11, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 11, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 11, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 14, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 12, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 12, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 12, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 13, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 11, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 11, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 11, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 12, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 12, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 12, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 12, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 3, 2020 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Dec 3, 2020 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Nov 2, 2020 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Nov 14, 2019 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Nov 7, 2019 | OPPF | T | OPPOSITION PAPERS RECEIVED AT TTAB | Loading... |
| Oct 8, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 8, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 18, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 5, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 3, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 24, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 23, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 23, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 26, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 12, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 26, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"